𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary extranodal lymphoma. Response to treatment and factors influencing prognosis

✍ Scribed by Richard A. Rudders; Michael E. Ross; Ronald A. Delellis

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
766 KB
Volume
42
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mitoxantrone and intermediate-dose cytos
Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: Response to treatment and factors influencing outcome
✍ Dr Jorge Sierra; Albert GraΓ±ena; Francesc Bosch; Enric Carreras; Josep-Maria Mar πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 574 KB

Mitoxantrone (MIT, 12 mg/m', i.v. 5 days) and intermediate-dose cytosine arabinoside (IDAC 1 g/m2/12 h, i.v. 3 days) was given to 43 patients with poor-risk acute leukemias (AL). Moderate or severe toxicity was infrequent. The proportion of complete remissions (CR) in the main patient categories was